Dipstick proteinuria as a surrogate marker of long-term mortality after acute myocardial infarction

Hisanobu Ota1, Toshiharu Takeuchi, Nobuyuki Sato

  • 1Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.

Journal of Cardiology
|June 29, 2013
PubMed

Insights

Proteinuria, not reduced estimated glomerular filtration rate (eGFR), is a significant predictor of long-term mortality after acute myocardial infarction (AMI). Early detection of proteinuria can identify high-risk patients for improved outcomes.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Research

Background:

  • Proteinuria and reduced estimated glomerular filtration rate (eGFR) are linked to increased mortality risk following acute myocardial infarction (AMI).
  • The comparative prognostic value of proteinuria versus eGFR for all-cause mortality post-AMI remains unclear.

Purpose of the Study:

  • To compare the prognostic value of proteinuria and eGFR for predicting all-cause mortality in patients after AMI.
  • To investigate the association of proteinuria and eGFR with brain natriuretic peptide (BNP) levels and long-term mortality.

Main Methods:

  • 101 patients admitted with AMI undergoing angioplasty were assessed for dipstick proteinuria and eGFR on admission.
  • Patients were grouped based on the presence/absence of proteinuria and eGFR levels (<60 vs. >60 mL/min/1.73m²).
  • 3-year all-cause mortality was evaluated using Kaplan-Meier analysis and a multivariate Cox proportional hazards model.

Main Results:

  • Higher BNP levels were observed in patients with proteinuria and lower eGFR.
  • Both proteinuria and lower eGFR were associated with significantly higher 3-year all-cause mortality.
  • Proteinuria, but not lower eGFR, was identified as an independent predictor of all-cause mortality in the Cox model.

Conclusions:

  • Dipstick proteinuria and reduced eGFR in early AMI follow-up correlate with elevated BNP and adverse long-term outcomes.
  • Dipstick proteinuria emerges as a potentially valuable prognostic marker for long-term all-cause mortality after AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...